Overview

Milrinone Inhaled in Cardiac Surgery

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Pulmonary hypertension is an important morbidity factor in patients having to undergo cardiac surgery with cardiopulmonary bypass (ECC). Milrinone used in inhalation, shows evidence of being a pulmonary vasodilator able to possibly contribute to the reduction of pressure on the pulmonary artery.
Phase:
Phase 2
Details
Lead Sponsor:
Andre Denault
Collaborators:
Canadian Anesthesiologists' Society
Heart and stoke fondation of Quebec
Organon
Treatments:
Milrinone